Compare with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs TORRENT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES TORRENT PHARMA ALKEM LABORATORIES/
TORRENT PHARMA
 
P/E (TTM) x 20.9 36.0 58.0% View Chart
P/BV x 4.8 7.5 63.3% View Chart
Dividend Yield % 1.0 1.4 75.8%  

Financials

 ALKEM LABORATORIES   TORRENT PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-21
TORRENT PHARMA
Mar-21
ALKEM LABORATORIES/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs3,1503,040 103.6%   
Low Rs2,2241,933 115.0%   
Sales per share (Unadj.) Rs741.4473.0 156.7%  
Earnings per share (Unadj.) Rs135.374.0 182.9%  
Cash flow per share (Unadj.) Rs158.3112.9 140.2%  
Dividends per share (Unadj.) Rs30.0035.00 85.7%  
Avg Dividend yield %1.11.4 79.3%  
Book value per share (Unadj.) Rs616.8344.9 178.8%  
Shares outstanding (eoy) m119.57169.22 70.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.65.3 68.9%   
Avg P/E ratio x19.933.6 59.1%  
P/CF ratio (eoy) x17.022.0 77.0%  
Price / Book Value ratio x4.47.2 60.4%  
Dividend payout %22.247.3 46.9%   
Avg Mkt Cap Rs m321,244420,798 76.3%   
No. of employees `000NANA-   
Total wages/salary Rs m16,21014,396 112.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m88,65080,048 110.7%  
Other income Rs m2,332757 307.9%   
Total revenues Rs m90,98280,806 112.6%   
Gross profit Rs m19,42424,666 78.7%  
Depreciation Rs m2,7466,578 41.7%   
Interest Rs m5893,583 16.4%   
Profit before tax Rs m18,42115,263 120.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2432,744 81.8%   
Profit after tax Rs m16,17812,519 129.2%  
Gross profit margin %21.930.8 71.1%  
Effective tax rate %12.218.0 67.7%   
Net profit margin %18.215.6 116.7%  
BALANCE SHEET DATA
Current assets Rs m69,28855,232 125.4%   
Current liabilities Rs m36,04148,916 73.7%   
Net working cap to sales %37.57.9 475.3%  
Current ratio x1.91.1 170.3%  
Inventory Days Days2014 136.3%  
Debtors Days Days667 952.7%  
Net fixed assets Rs m34,82581,298 42.8%   
Share capital Rs m239846 28.3%   
"Free" reserves Rs m73,51757,526 127.8%   
Net worth Rs m73,75658,372 126.4%   
Long term debt Rs m34329,633 1.2%   
Total assets Rs m104,114136,530 76.3%  
Interest coverage x32.35.3 613.4%   
Debt to equity ratio x00.5 0.9%  
Sales to assets ratio x0.90.6 145.2%   
Return on assets %16.111.8 136.6%  
Return on equity %21.921.4 102.3%  
Return on capital %25.721.4 119.8%  
Exports to sales %22.10-   
Imports to sales %00-   
Exports (fob) Rs m19,555NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,55521,539 90.8%   
Fx outflow Rs m2,4677,136 34.6%   
Net fx Rs m17,08814,403 118.6%   
CASH FLOW
From Operations Rs m12,64920,107 62.9%  
From Investments Rs m-9,985-4,494 222.2%  
From Financial Activity Rs m-2,718-16,561 16.4%  
Net Cashflow Rs m-17-893 1.9%  

Share Holding

Indian Promoters % 57.1 71.3 80.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 19.6 20.6 94.8%  
FIIs % 5.4 10.9 49.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.9 28.8 149.1%  
Shareholders   81,869 63,229 129.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Ends 236 Points Lower, Nifty Falls Below 16,150; IT & FMCG Stocks Witness Selling(Closing)

Indian share markets ended on a negative note today as global cues remained weak.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


May 24, 2022 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS